Improved detection of hepatitis B virus surface antigen by a new rapid automated assay

Journal of Clinical Microbiology

Volumn 37, Issue 8, 1999, Pages 2639-2647

  Weber, Bernard ^a,b   Bayer, Anja ^c   Kirch, Peter ^c   Schlüter, Volker ^c,d   Schlieper, Dietmar ^c   Melchior, Walter ^c  

^a Laboratoires Reunis Kutter Lieners Hastert Centre Langwies   (Luxembourg)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d MediGene AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; COMPUTER ASSISTED DIAGNOSIS; ENZYME IMMUNOASSAY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; SEROCONVERSION;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032774139     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.8.2639-2647.1999     Document Type: Article

References (43)

1. Berger, A., H. W. Doerr, H. F. Rabenau, M. Teebrücke, and B. Weber. Epidemiological analysis of the significance of positive test results for antibody to hepatitis B core antigen (anti-HBc). Submitted for publication.
2. Bréchot, C., F. Degos, C. Lugassy, V. Thiers, S. Zafrani, D. Franco, H. Bismuth, C. Trépo, J. Benhamou, J. Wands, K. Isselbacher, P. Tiollais, and P. Berthelot. 1985. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N. Engl. J. Med. 312:270-276.
3. Bréchot, C., D. Kremsdorf, P. Paterlini, and V. Thiers. 1991. Hepatitis B virus DNA in HBsAg-negative patients: molecular characterization and clinical implications. J. Hepatol. 4:S49-S55.
4. Brunetto, M. R., M. T. Cerenzia, F. Oliveri, P. Piantino, A. Randone, P. L. Calvo, G. Rocca, C. Galli, and F. Bonino. 1993. Monitoring the natural course and response to therapy of chronic hepatitis B with a semi-quantitative assay for IgM anti-HBc. J. Hepatol. 19:431-436.
5. Bünung, H., and G. Trenkler. 1978. Nicht-parametrierbare Methoden. Springer-Verlag, Berlin, Germany.
6. Carman, W. F. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J. Viral Hepat. 4(Suppl. 1):S11-S20.
7. Carman, W. F., and L. T. Mimms. 1997. Pre-S/S gene variants of hepatitis B virus, p. 108-115. In M. Rizetto, R. H. Purcell, J. L. Gerin, and G. Verne (ed.), Viral hepatitis and liver disease. Edizioni Minerva Medica, Torino, Italy.
8. Carman, W. F., A. R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, E. Tanzi, A. J. Zuckerman, and H. C. Thomas. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
9. Carman, W. F., F. J. Van Deursen, L. T. Mimms, D. Hardie, R. Coppola, R. Decker, and R. Sanders. 1997. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658-1666.
10. Courouce-Pauty, A. M., A. Plancon, and J. P. Soulier. 1983. Distribution of HBsAg subtypes in the world. Vox Sang. 35:197-211.
11. Coursaget, P., B. Yvonnet, C. Bourdil, M. N. Mevelec, P. Adarnowicz, J. L. Barres, J. Chotard, R. N'Doye, I. Diop Mar, and J. P. Chiron. 1987. HBsAg positive reactivity in a man not due to hepatitis B virus. Lancet ii:1354-1358.
12. Dodson, S. F., S. Issa, V. Araya, T. Gayowski, A. Pinna, B. Eghtesad, S. Iwatsuki, E. Montalvo, J. Rakela, and J. Fung. 1997. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 64:1582-1584.
13. Fortuin, M., V. Karthigesu, L. Allison, C. Howard, S. Hoare, M. Mendy, and H. C. Witthle. 1994. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J. Infect. Dis. 169:1374-1376.
14. Gross, A., H. I. Joller-Jemelka, A. N. Wicki, and P. J. Grob. 1993. Der Hepatitis-serologische Befund "Anti-HBc allein", zirkulierende virale DNS und Befund-Interpretation. Schweiz. Med. Wochenschr. 123:1193-1202.
15. Hadler, S. C., B. L. Murphy, C. A. Schable, W. L. Heyward, D. P. Francis, and M. A. Kane. 1984. Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J. Clin. Microbiol. 19:521-525.
16. Hall, J., W. Jilg, B. Hottenträger, P. Bonnar, C. Fang, and L. Baker. 1998. Performance of a chemiluminescent immunoassay for HBsAg on the new high-throughput and fully automated ACS: Centaur™ system. Clin. Lab. 44:349-354.
17. Hoofnagle, J. 1990. Post-transfusion hepatitis B. Transfusion 30:384-386.
18. Howard, C. R. 1995. The structure of hepatitis B envelope and molecular variants of hepatitis B virus. J. Viral Hepat. 2:165-170.
19. Howard, C. R., and L. M. C. Allison. 1995. Hepatitis B surface antigen variation and protective immunity. Intervirology 38:35-40.
20. Jilg, W., E. Sieger, R. Zachoval, and H. Schätzl. 1995. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J. Hepatol. 23:14-20.
21. Kojima, M., M. Shinizu, T. Tsuchimochi, M. Koyasu, S. Tanaka, H. Iizuka, T. Tanaka, H. Okamoto, F. Tsuda, and Y. Miyakowa. 1991. Post-transfusion fulminant hepatitis B associated with pre-core defective HBV mutants. Vox Sang. 60:34-39.
22. Lai, K. N., F. M. M. Lai, N. W. Y. Leung, S. Lo, and J. S. Tam. 1990. Hepatitis with isolated serum antibody to hepatitis B core antigen. Am. J. Clin. Pathol. 93:79-83.
23. Lazizi, Y., P. Dubreuil, and J. Pillot. 1993. Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers. Virology 17:966-970.
24. Lee, H. S., M. S. Rajagopalan, D. Chien, R. Cordell, H. A. Perkins, and G. N. Vyas. 1987. Specificity of enzyme immunoassays for hepatitis B core antibody used in screening blood donors. Transfusion 27:103-106.
25. Lee, J. H., T. G. Paglieroni, P. V. Holland, and J. B. Zeldis. 1992. Chronic hepatitis B virus infection in an HBc antibody-nonreactive blood donor: variant virus or defective immune response? Hepatology 16:24-30.
26. Norder, H., B. Hammas, S. Lofdahl, A. M. Courouce, and L. O. Magnius. 1992. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and the genomic classification of the corresponding hepatitis B virus strains. J. Gen. Virol. 73:1201-1208.
27. Norder, H., B. Hammas, S. D. Lee, K. Bile, A. M. Courouce, I. K. Mushahwar, and L. O. Magnius. 1993. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J. Gen. Virol. 74:1341-1348.
28. Oon, C. J., G. K. Lim, Z. Ye, K. T. Goh, K. I. Tan, S. L. Yo, and E. Hopes. 1995. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13:699-702.
29. Palmer, D. R., K. R. Perry, P. P. Mortimer, J. V. Parry, P. Garden, and J. Dhell. 1995. An evaluation of fifteen HBsAg screening assays. Medical Devices Agency, London, England.
30. Ramesh, A. B., P. P. Ulrich, and G. N. Vyas. 1990. Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology 11:271-276.
31. Ratnam, S., F. Stead, and C. B. Head. 1989. False-positive results with third-generation monoclonal hepatitis B surface antigen enzyme immunoassay. J. Clin. Microbiol. 27:2102-2104.
32. Sanchez-Quijano, A., J. I. Jauregui, M. Leal, J. A. Pineda, A. Castilla, M. A. Abad, M. P. Civeira, F. Garcia de Pesquera, J. Prieto, and E. Lissen. 1993. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J. Hepatol. 17:288-293.
33. Scheitlin, T. H., and P. J. Grob. 1992. Infektionen mit den Hepatitisviren HAV, HBV und HCV sowie mit dem AIDS Virus HIV bei Drogenabhängigen der Cassenszene Zürichs: eine Prävalenzstudie. Schweiz. Med. Wochenschr. 120:621-629.
34. Shih, L., J. Sheu, J. Wang, G. Huang, P. Yang, H. Lee, J. Sung, T. Wang, and D. Chen. 1990. Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J. Med. Virol. 32: 257-260.
35. Skurrie, I. J., and S. M. Garland. 1988. False positivity with third-generation (monoclonal) assay for hepatitis B surface antigen. Lancet i:299-300.
36. Stirk, H. J., J. M. Thornton, and C. R. Howard. 1992. A topological model for hepatitis B surface antigen. Intervirology 33:148-158.
37. Sumazaki, R., M. Motz, H. Wolf, J. Heinig, W. Jilg, and F. Deinhardt 1989. Detection of hepatitis B virus in serum using amplification of DNA by means of polymerase chain reaction. J. Med. Virol. 27:304-308.
38. Thiers, V., E. Nakajima, D. Kremsdorf, D. Mack, H. Schellekens, F. Driss, A. Goudeau, J. Wands, J. Sninsky, P. Tiollais, and C. Brechot. 1988. Transmission of hepatitis B from hepatitis B-seronegative subjects. Lancet ii:1273-1276.
39. Vyas, G. N., S. N. Cohen, and R. Schmid (ed.). 1978. Viral hepatitis. Franklin Institute Press, Philadelphia, Pa.
40. Wallace, L. A., J. E. Echevarria, J. M. Echevarria, and W. F. Carman. 1994. Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J. Infect. Dis. 170:1300-1303.
41. Wang, J. T., T. H. Wang, J. C. Sheu, L. N. Shih, J. T. Lin, and D. S. Chen. 1991. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J. Infect. Dis. 163:397-399.
42. Waters, J., M. Kennedy, P. Voet, P. Hauser, J. Petre, W. Carman, and H. C. Thomas. 1992. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Investig. 90:2543-2547.
43. Weinberger, K. M., E. A. Kreuzpainter, B. Hottenträger, S. Neifer, and W. Jilg. 1997. Mutations in the s-gene of hepatitis B virus isolates from chronic carriers with anti-HBc as the only serological marker of HBV infection, p. 138-143. In M. Rizetto, R. H. Purcell, J. L. Gerin, and G. Verne (ed.), Viral hepatitis and liver disease. Edizioni Minerva Medica, Torino, Italy.